The reduced PDCD5 protein is correlated with the degree of tumor differentiation in endometrioid endometrial carcinoma

SpringerPlus

Table 1 Association analysis of PDCD5 expression in endometrioid adenocarcinoma tissues and clinicopathologic parameters

Clinical and pathological features	PDCD5 expression
Clinical and pathological features	n	Negative-moderate	Strong	P value
Age
≤55	20	17	3	0.3359
>55	30	28	2	0.3359
Myometrial invasion (%)
≤50	31	27	4	0.8192
>50	19	18	1	0.8192
FIGO stage
IA–IB	33	29	4	0.4861
IC–II	17	16	1	0.4861
Tumor differentiation degree
High differentiation	11	8	3	0.0278*
Middle-low differentiation	40	38	2	0.0278*
Estrogen receptor
Negative-weak	11	10	1	0.7703
Moderate-strong	31	29	2	0.7703
Progestin receptor
Negative-weak	11	10	1	0.7703
Moderate-strong	31	29	2	0.7703